Posts

Patenting the use of medical devices (T 0941/24)

Inherent anticipation of second medical use claims in New Zealand and Australia

EPO pharma case law trends 2025: Clinical inventions

Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23)

First UPC decision to tackle infringement and validity of second medical claims (Sanofi v Amgen, UPC_CFI_505/2024)

Fordham 32 (Report 1): Patents in Pharma

Never Too Late: If you missed the IPKat last week!

A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22)